Strong pre-existing T cell infiltration, IFN-γ–related gene expression signatures in the tumor and high serum level of IFN-γ were reported to be associated with a good clinical prognosis and to predict the response to anti-PD-1 therapy in melanoma patients [101,102,103,104,105]. This evidence concerns the gene PDCD1 and melanoma.